| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |